当前位置: X-MOL 学术Biochimie › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Structural basis for the design of selective inhibitors for Schistosoma mansoni dihydroorotate dehydrogenase
Biochimie ( IF 3.9 ) Pub Date : 2019-01-19 , DOI: 10.1016/j.biochi.2019.01.006
M. Cristina Nonato , Ricardo A.P. de Pádua , Juliana S. David , Renata A.G. Reis , Giovani P. Tomaleri , Humberto D'Muniz Pereira , Felipe A. Calil

Trematode worms of the genus Schistosoma are the causing agents of schistosomiasis, a parasitic disease responsible for a considerable economic and healthy burden worldwide. In the present work, the characterization of the enzyme dihydroorotate dehydrogenase from Schistosoma mansoni (SmDHODH) is presented. Our studies demonstrated that SmDHODH is a member of class 2 DHODHs and catalyzes the oxidation of dihydroorotate into orotate using quinone as an electron acceptor by employing a ping-pong mechanism of catalysis. SmDHODH homology model showed the presence of all structural features reported for class 2 DHODH enzymes and reveal the presence of an additional protuberant domain predicted to fold as a flexible loop and absent in the other known class 2 DHODHs. Molecular dynamics simulations showed that the ligand-free forms of SmDHODH and HsDHODH undergo different rearrangements in solution. Well-known class 2 DHODH inhibitors were tested against SmDHODH and HsDHODH and the results suggest that the variable nature of the quinone-binding tunnel between human and parasite enzymes, as well as the differences in structural plasticity involving rearrangements of the N-terminal α-helical domain can be exploited for the design of SmDHODH selective inhibitors, as a strategy to validate DHODH as a drug target against schistosomiasis.



中文翻译:

曼氏血吸虫曼森尼二氢乳清酸酯脱氢酶选择性抑制剂设计的结构基础

血吸虫属的吸虫线虫是血吸虫病的病原体,血吸虫病是一种寄生虫病,在世界范围内造成相当大的经济和健康负担。在目前的工作中,提出了曼氏血吸虫的双氢乳清酸脱氢酶(Sm DHODH)的表征。我们的研究表明,Sm DHODH是2类DHODHs的成员,并通过采用乒乓催化机制,以醌作为电子受体,催化二氢乳清酸盐氧化为乳清酸盐。mDHODH同源性模型显示了2类DHODH酶报告的所有结构特征的存在,并揭示了另外一个突起结构域的存在,该结构域预计会折叠为柔性环,而在其他已知的2类DHODHs中不存在。分子动力学模拟表明,Sm DHODH和Hs DHODH的无配体形式在溶液中会发生不同的重排。测试了著名的2类DHODH抑制剂对Sm DHODH和Hs DHODH的抑制作用,结果表明人与寄生虫酶之间醌结合通道的可变性质,以及涉及N端重排的结构可塑性的差异α-螺旋结构域可用于Sm的设计DHODH选择性抑制剂,作为验证DHODH作为抗血吸虫病药物靶点的策略。

更新日期:2019-01-19
down
wechat
bug